Cooley advised HBM Healthcare Investments and certain other investors on their lead investment in Harmony Biosciences’ completed $270 million equity financing. Harmony used the proceeds of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now